RxDoctor Payments Data

Monica Crane, MD

Geriatric Medicine · Knoxville, TNNPI 1982713053

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,920 of the $6,762 with a category attached, or 72.8%. Biogen accounts for 97.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $2,870 and has fallen 97.2% since, to $80 in 2025. Among geriatric medicine clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,762in general payments, 2019–2025

Across 6 payments — averaging $1127.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$7K
  • Novo Nordisk$106
  • F. Hoffmann-la Roche AG$80
  • Lilly USA, LLC$16
$1,263,145in research payments, 2019–2025

Across 142 payments — averaging $8895.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$484K
  • Roche Diagnostics Operations, Inc.$243K
  • Biogen$236K
  • Eli Lilly$159K
  • Acadia Pharmaceuticals Inc$109K
  • Genentech, Inc.$24K
  • plus $7K from 1 others

What the payments were for

  • Consulting fees$1,64024%
  • Speaking & faculty fees$4,92073%
  • Food & beverage$2023%

General payments by program year

20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen3$6,560
Novo Nordisk1$106
F. Hoffmann-la Roche AG1$80
Lilly USA, LLC1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,762 in reported general payments places this provider in the 90th percentile of 46 geriatric medicine providers in Tennessee.

See all geriatric medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$164,718
Medicare patients
599
Services billed
1,368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Galantamine ErGalantamine Hbr328$31,192
Rivastigmine115$30,467
Memantine Hcl900$22,358
Donepezil Hcl621$5,946
Memantine Hcl ErMemantine Hcl17$3,736
Carbidopa-LevodopaCarbidopa/Levodopa44$759
Mirtazapine15$427
Duloxetine Hcl13$378
Quetiapine Fumarate37$351
Sertraline Hcl24$296
Escitalopram Oxalate23$183
Divalproex Sodium15$138

Paid to pharmacies, not to this prescriber.

Other geriatric medicine in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →